Table 2.
Follow-up clinical characteristics of wounded warriors requiring RRT for AKI managed in the National Capital Region who survived hospitalization (n=40)
| Demographic Features | Value | ||
|---|---|---|---|
| Age at injury (y) | 25±5 | ||
| Age at last follow-up (y) | 29±6 | ||
| Death during follow-up | 1 (2.5) | ||
| Time from injury to last follow-up (d) | 1326 (219–3318) | ||
| Sex, male:female | 39:1 | ||
| Race | |||
| White | 26 (65) | ||
| Black | 8 (15) | ||
| Other | 6 (20) | ||
| ESRD (present at hospital discharge) | 1 (2.5) | ||
| Kidney function (n=39, without ESRD at hospital discharge) | |||
| Serum creatinine at hospital discharge (mg/dl) | 0.80±0.36 | ||
| Time from injury to last serum creatinine (d) | 1158 (99–3316) | ||
| Serum creatinine at last follow-up | 0.85±0.24 | ||
| eGFR (CKD-EPI) at last follow-up (ml/min per 1.73 m2) | 118±23 | ||
| eGFR≤60 ml/min per 1.73 m2 | 0 (0) | ||
| HTN present at last follow-up | 8 (21) | ||
| Proteinuria present at last follow-up (n=36) | 9 (25) | ||
| Calcium at last follow-up (n=32) (mg/dl) | 9.6±0.7 | ||
| Phosphate at last follow-up (n=13) (mg/dl) | 3.7±0.9 | ||
| Hemoglobin at last follow-up (n=26) (g/dl) | 13.8±2.4 | ||
| Nephrolithiasis by history or imaging | 7 (18) | ||
| Neurogenic bladder | 7 (18) | ||
| Amputation and Renal Function (n=39, without ESRD at hospital discharge) | |||
| Degree of Amputation | Serum Creatinine at Last Follow-Up (mg/dl) | eGFR (CKD-EPI) at Last Follow-Up (ml/min per 1.73 m2) | |
| None (n=12) | 0.86±0.30 | 117±27 | |
| Small (n=6) | 1.00±0.18 | 107±20 | |
| Medium (n=8) | 0.82±0.14 | 121±11 | |
| Large (n=13) | 0.81±0.26 | 122±26 | |
Data are presented as mean±SD, median (range), or count (%). CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; HTN, hypertension.